Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV:DM, FSE:D4G) is pleased to announce that its newly formed subsidiary, Canntop AI Inc. (“Canntop AI”), will leverage Nexalogy’s strong experience working on AI solutions for the vaping sector. Canntop AI will continue to use Nexalogy’s technology to become a leading provider of social data analysis in the Cannabis space.

Nexalogy has a multi-year track record of successfully working with various Canadian federal agencies including Health Canada. One of the programs Nexalogy has worked on with Health Canada was focused on the vaping industry. Nexalogy’s technology targeted key trends and social discovery, allowing Health Canada to have deeper insight into usage and patterns. As a proven solution provider to the Federal Government, we believe that we are well positioned to bid on new projects providing social data insights to multiple agencies. The Cannabis sector is expected to grow significantly, generating massive amounts of social data that will need to be collected, scrubbed and analyzed.


We created Canntop AI to focus on the Cannabis sector as we have seen the positive results of our solutions and work in the vaping area and anticipate that the Cannabis space will benefit strongly from our technology. Canntop AI will focus on the Cannabis market, including insight and analytical data on cosmetics, CBD, recreational and medical use, as well as consumables.

“This is a tremendous opportunity for Datametrex to build on existing relationships and previous contracts with various Government Agencies. We believe there will be tremendous demand by various groups for clear, concise and actionable social data analysis surrounding the Cannabis sector. Creating Canntop AI demonstrates our commitment to becoming a global leader in this marketplace,” says Andrew Ryu, CEO and Chairman of the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to four exciting verticals. Big data, Artificial intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Implementing Blockchain technology for secure data transfers through its joint venture company, Graph Blockchain Limited (www.graphblockchain.com). Industrial scale cryptocurrency mining through its wholly owned subsidiary, Ronin Blockchain Corp. (www.roninblockchain.com).

Additional information on Datametrex is available at: www.datametrex.com

To stay informed about Datametrex, please join our Investor Group on 8020 Connect http://bit.ly/2fPUNwF for all upcoming news releases, articles comments and questions.

For further information, please contact:

Jeffrey Stevens – President & COO
Phone: (647) 400-8494
Email: jstevens@datametrex.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Forward-looking information is not a guarantee of future performance or results, since it involves risks and uncertainties. There is no assurance that forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in forward-looking statements. Except as required by law, the Company does not assume and expressly renounces any obligation to update any forward-looking information, which is only applicable on the date on which it is given.

Source: globenewswire.com

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less